ADENOVIRUS INFECTION
Clinical trials for ADENOVIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new ADENOVIRUS INFECTION trials appear
Sign up with your email to follow new studies for ADENOVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can 'Supercharged' donor cells beat viruses that drugs Can't?
Disease control Recruiting nowThis study tests whether giving patients special donor immune cells (called CD45RA-depleted DLI) can treat viral infections that persist after a stem cell transplant. The trial involves 30 participants who have not improved with standard antiviral drugs. Researchers will measure …
Matched conditions: ADENOVIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Supercharged immune cells take on Drug-Resistant infections
Disease control Recruiting nowThis trial investigates whether specially grown immune cells, called pathogen-specific cytotoxic T lymphocytes (CTLs), can safely and effectively treat stubborn infections like EBV, CMV, and adenovirus in people with weakened immune systems, such as stem cell or organ transplant …
Matched conditions: ADENOVIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Donor immune cells take on tough viruses in transplant patients
Disease control Recruiting nowThis early-stage trial tests whether specially grown immune cells from a donor can safely help transplant patients fight off viral infections that standard treatments can't control. The cells target Epstein-Barr virus, cytomegalovirus, adenovirus, and BK virus. Up to 36 adults wh…
Matched conditions: ADENOVIRUS INFECTION
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Engineered immune cells take on viruses in cancer patients
Disease control Recruiting nowThis early-stage trial is testing whether genetically modified T-cells can safely control viral infections in cancer patients with weakened immune systems. The T-cells are designed to target specific viruses like CMV, BK virus, or COVID-19. The study involves 30 participants and …
Matched conditions: ADENOVIRUS INFECTION
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Scientists hunt for clues in COVID Patients' blood and secretions
Knowledge-focused Recruiting nowThis study collects blood and nasal secretions from up to 2,000 people with COVID-19 to learn why some get very sick while others recover easily. Researchers will also track long-term symptoms like fatigue and brain fog. No treatments are tested—the goal is to gather data to guid…
Matched conditions: ADENOVIRUS INFECTION
Sponsor: Tulane University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC